{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T07:22:41Z","timestamp":1792740161242,"version":"4.5.0"},"reference-count":57,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2005,3,22]],"date-time":"2005-03-22T00:00:00Z","timestamp":1111449600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transfusion"],"published-print":{"date-parts":[[2005,4]]},"abstract":"<jats:p><jats:bold>BACKGROUND:<\/jats:bold> Viral contamination of platelet (PLT) concentrates can result in transfusion\u2010transmitted diseases. A photochemical treatment (PCT) process with amotosalen\u2010HCl and long\u2010wavelength ultraviolet light (UVA), which cross\u2010links nucleic acids, was developed to inactivate viruses and other pathogens in PLT concentrates.<\/jats:p><jats:p><jats:bold>STUDY DESIGN AND METHODS:<\/jats:bold> High titers of pathogenic or blood\u2010borne viruses, representing 10 different families, were added to single\u2010donor PLT concentrates containing 3.0\u2003\u00d7\u200310<jats:sup>11<\/jats:sup> to 6.0\u2003\u00d7\u200310<jats:sup>11<\/jats:sup> PLTs in approximately 300\u2003mL of 35\u2003percent plasma and 65\u2003percent PLT additive solution (InterSol). After PCT with 150\u2003\u00b5mol per L amotosalen and 3\u2003J per cm<jats:sup>2<\/jats:sup> UVA, residual viral infectivity was assayed by sensitive cell culture or animal systems.<\/jats:p><jats:p><jats:bold>RESULTS:<\/jats:bold> Enveloped viruses were uniformly sensitive to inactivation by PCT whereas nonenveloped viruses demonstrated variable inactivation. Log reduction of enveloped viruses for cell\u2010free HIV\u20101 was &gt;6.2; for cell\u2010associated HIV\u20101, &gt;6.1; for clinical isolate HIV\u20101, &gt;3.4; for clinical isolate HIV\u20102, &gt;2.5; for HBV, &gt;5.5; for HCV, &gt;4.5; for DHBV, &gt;6.2; for BVDV, &gt;6.0; for HTLV\u2010I, 4.2; for HTLV\u2010II, 4.6; for CMV, &gt;5.9; for WNV, &gt;5.5; for SARS\u2010HCoV, &gt;5.8; and for vaccinia virus, &gt;4.7. Log reduction of nonenveloped viruses for human adenovirus 5 was &gt;5.2; for parvovirus B19, 3.5\u2010&gt;5.0; for bluetongue virus, 5.6\u20105.9; for feline conjunctivitis virus, 1.7\u20102.4; and for simian adenovirus 15, 0.7\u20102.3.<\/jats:p><jats:p><jats:bold>CONCLUSION:<\/jats:bold> PCT inactivates a broad spectrum of pathogenic, blood\u2010borne viruses. Inactivation of viruses in PLT concentrates with amotosalen and UVA offers the potential to prospectively prevent the majority of PLT transfusion\u2010associated viral diseases.<\/jats:p>","DOI":"10.1111\/j.0041-1132.2005.04316.x","type":"journal-article","created":{"date-parts":[[2005,3,22]],"date-time":"2005-03-22T16:59:56Z","timestamp":1111510796000},"page":"580-590","source":"Crossref","is-referenced-by-count":146,"title":["Inactivation of viruses in platelet concentrates by photochemical treatment with amotosalen and long\u2010wavelength ultraviolet light"],"prefix":"10.1111","volume":"45","author":[{"given":"Lily","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl V.","family":"Hanson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harvey J.","family":"Alter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie","family":"Jauvin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristen A.","family":"Bernard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krishna K.","family":"Murthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peyton","family":"Metzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Corash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2005,3,22]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199902113400606"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.2002.00174.x"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.2000.40020143.x"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2004.03364.x"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.0042-9007.2004.00406.x"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.2003.00481.x"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200404083501523"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.42.4.1471-1476.2004"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-10-3143"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-03-0762"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0037-1963(01)90118-0"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-03-0932"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-12-4443"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1997.37497265344.x"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1159\/000053391"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1423-0410.2000.7840209.x"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0037-1963(01)90121-0"},{"issue":"1","key":"e_1_2_6_19_2","first-page":"228","article-title":"The INTERCEPT blood system for platelets inactivates high titers of a variety of blood\u2010borne pathogens in platelets","volume":"4","author":"Sawyer L","year":"2003","journal-title":"Hematol J"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2004.04125.x"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/1045-1056(91)90044-K"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.2003.00584.x"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.6600519"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.28.9.2030-2034.1990"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/0042-6822(90)90431-P"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.62.1.139-147.1988"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/0168-1702(93)90099-9"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/0166-0934(94)00097-Z"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1996.36596282583.x"},{"key":"e_1_2_6_30_2","first-page":"493","article-title":"A simple method of estimating fifty\u2010 per cent endpoints","volume":"27","author":"Reed LJ","year":"1938","journal-title":"Am J Hyg"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/132.4.451"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/144.6.588"},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(88)90931-2"},{"key":"e_1_2_6_34_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.76.12.5847-5856.2002"},{"key":"e_1_2_6_35_2","first-page":"C","volume-title":"ELISpot assay for the sensitive detection of infectious Parvovirus B19 [abstract].","author":"Hanson D","year":"2003"},{"key":"e_1_2_6_36_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.bi.56.070187.003251"},{"key":"e_1_2_6_37_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.2523562"},{"key":"e_1_2_6_38_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V91.6.2180"},{"key":"e_1_2_6_39_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.47.2.475-479.2003"},{"key":"e_1_2_6_40_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.2002.00158.x"},{"key":"e_1_2_6_41_2","first-page":"86A","article-title":"Inactivation of human parvovirus B19 by INACTINE PEN110","volume":"43","author":"Lazo A","year":"2003","journal-title":"Transfusion"},{"key":"e_1_2_6_42_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid1003.030683"},{"key":"e_1_2_6_43_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)15486-X"},{"key":"e_1_2_6_44_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid1006.031082"},{"key":"e_1_2_6_45_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2004.03420.x"},{"key":"e_1_2_6_46_2","first-page":"102A","article-title":"Inactivation of parvovirus B19 in platelets by helinx technology","volume":"44","author":"Sawyer L","year":"2004","journal-title":"Transfusion"},{"key":"e_1_2_6_47_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa030747"},{"key":"e_1_2_6_48_2","doi-asserted-by":"publisher","DOI":"10.1159\/000076974"},{"key":"e_1_2_6_49_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa030969"},{"key":"e_1_2_6_50_2","first-page":"281","article-title":"Update: West Nile virus screening of blood donations and transfusion\u2010associated transmission\u2014United States, 2003","volume":"53","author":"Centers for Disease Control and Prevention.","year":"2004","journal-title":"MMWR"},{"key":"e_1_2_6_51_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1423-0410.2003.00315.x"},{"key":"e_1_2_6_52_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V79.3.826.826"},{"key":"e_1_2_6_53_2","first-page":"79","article-title":"Virus inactivated single\u2010donor fresh plasma preparations","volume":"19","author":"Mohr H","year":"1992","journal-title":"Infusionsther Transfusionsmed"},{"key":"e_1_2_6_54_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1989.29789369683.x"},{"key":"e_1_2_6_55_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.0042-9007.2004.00515.x"},{"key":"e_1_2_6_56_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1994.34694295069.x"},{"key":"e_1_2_6_57_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.2002.00221.x"},{"key":"e_1_2_6_58_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2004.03355.x"}],"container-title":["Transfusion"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.0041-1132.2005.04316.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.0041-1132.2005.04316.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T04:45:45Z","timestamp":1697258745000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.0041-1132.2005.04316.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,3,22]]},"references-count":57,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2005,4]]}},"alternative-id":["10.1111\/j.0041-1132.2005.04316.x"],"URL":"https:\/\/doi.org\/10.1111\/j.0041-1132.2005.04316.x","archive":["Portico"],"relation":{},"ISSN":["0041-1132","1537-2995"],"issn-type":[{"value":"0041-1132","type":"print"},{"value":"1537-2995","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,3,22]]}}}